J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 75 (1994), 1999-2006; DOI 10.1099/0022-1317-75-8-1999
© 1994 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwarzmann, F.
Right arrow Articles by Wolf, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarzmann, F.
Right arrow Articles by Wolf, H.
Agricola
Right arrow Articles by Schwarzmann, F.
Right arrow Articles by Wolf, H.

Negatively cis-acting elements in the distal part of the promoter of Epstein—Barr virus trans-activator gene BZLF1

Fritz Schwarzmann, Nadja Prang, Bettina Reichelt{dagger}, Brigitte Rinkes, Stefan Haist, Manfred Marschall{ddagger} and Hans Wolf

Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Franz-Josef-Strauß-Allee 11, D-93053 Regensburg, Germany

Epstein—Barr virus (EBV) replicates in a latent or a lytic way in the infected organism, depending on the type and level of differentiation of the host cell. The switch between latency and lytic replication was previously shown, for Burkitt's lymphoma cell lines, to depend on the viral BZLF1 gene product. Protein-DNA assays were used to identify the cis-acting elements that represent the link between regulating signal transduction pathways and the viral cascade of gene expression. Specific binding of proteins to several sites of the BZLF1 promoter during latency was shown. Induction of the lytic cycle by stimulation with 12-O-tetradecanoylphorbol 13-acetate abolished the binding of these proteins to the distal promoter (positions -227 to -551), suggesting a functional role for the down-regulation of promoter activity during latency. Computer analysis identified a multiply repeated sequence motif, HI, in this region and exonuclease III footprints confirmed that these sites act as specific protein recognition sites. Using a set of reporter plasmids we were able to demonstrate a negative regulatory effect of the HI motif in some B lymphoid cell lines, in contrast to epithelial HeLa cells. The HI silencer elements are different from other silencer elements described so far in respect of their sequence and protein-binding pattern during the activation of BZLF1.

{dagger} Present address: Ludwig-Maximilians Universität München, Institut für Immunologie, Goethestraße 31, D-80336 München, Germany.

{ddagger} Present address: Institut für Medizinische Mikrobiologie und Hygiene, Technische Universität München, Biedersteinerstraße 29, D-80802 München, Germany.

Received 3 November 1993; accepted 8 February 1994.


This article has been cited by other articles:


Home page
J. Virol.Home page
F. Y. Wu, S. E. Wang, H. Chen, L. Wang, S. D. Hayward, and G. S. Hayward
CCAAT/Enhancer Binding Protein {alpha} Binds to the Epstein-Barr Virus (EBV) ZTA Protein through Oligomeric Interactions and Contributes to Cooperative Transcriptional Activation of the ZTA Promoter through Direct Binding to the ZII and ZIIIB Motifs during Induction of the EBV Lytic Cycle
J. Virol., May 1, 2004; 78(9): 4847 - 4865.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
C. Thomas, A. Dankesreiter, H. Wolf, and F. Schwarzmann
The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency
J. Gen. Virol., April 1, 2003; 84(4): 959 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. J. Kraus, J. G. Perrigoue, and J. E. Mertz
ZEB Negatively Regulates the Lytic-Switch BZLF1 Gene Promoter of Epstein-Barr Virus
J. Virol., December 6, 2002; 77(1): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
I. G. Miller Jr. and A. El-Guindy
Regulation of Epstein-Barr Virus Lytic Cycle Activation in Malignant and Nonmalignant Disease
J Natl Cancer Inst, December 4, 2002; 94(23): 1733 - 1735.
[Full Text] [PDF]


Home page
J. Virol.Home page
U. K. Binne, W. Amon, and P. J. Farrell
Promoter Sequences Required for Reactivation of Epstein-Barr Virus from Latency
J. Virol., September 11, 2002; 76(20): 10282 - 10289.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. H. Niller, D. Salamon, J. Uhlig, S. Ranf, M. Granz, F. Schwarzmann, H. Wolf, and J. Minarovits
Nucleoprotein Structure of Immediate-Early Promoters Zp and Rp and of oriLyt of Latent Epstein-Barr Virus Genomes
J. Virol., March 19, 2002; 76(8): 4113 - 4118.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. J. Kraus, S. J. Mirocha, H. M. Stephany, J. R. Puchalski, and J. E. Mertz
Identification of a Novel Element Involved in Regulation of the Lytic Switch BZLF1 Gene Promoter of Epstein-Barr Virus
J. Virol., January 15, 2001; 75(2): 867 - 877.
[Abstract] [Full Text]


Home page
J. Virol.Home page
P. J. Jenkins, U. K. Binné, and P. J. Farrell
Histone Acetylation and Reactivation of Epstein-Barr Virus from Latency
J. Virol., January 1, 2000; 74(2): 710 - 720.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. Menet, C. Speth, C. Larcher, W. M. Prodinger, M. G. Schwendinger, P. Chan, M. Jäger, F. Schwarzmann, H. Recheis, M. Fontaine, et al.
Epstein-Barr Virus Infection of Human Astrocyte Cell Lines
J. Virol., September 1, 1999; 73(9): 7722 - 7733.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
P MacCallum, L Karimi, and L. Nicholson
Definition of the transcription factors which bind the differentiation responsive element of the Epstein--Barr virus BZLF1 Z promoter in human epithelial cells
J. Gen. Virol., June 1, 1999; 80(6): 1501 - 1512.
[Abstract]


Home page
J. Virol.Home page
N. Greifenegger, M. Jager, L. A. Kunz-Schughart, H. Wolf, and F. Schwarzmann
Epstein-Barr Virus Small RNA (EBER) Genes: Differential Regulation during Lytic Viral Replication
J. Virol., November 1, 1998; 72(11): 9323 - 9328.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Liu, S. Liu, and S. H. Speck
Identification of a Negative cis Element within the ZII Domain of the Epstein-Barr Virus Lytic Switch BZLF1 Gene Promoter
J. Virol., October 1, 1998; 72(10): 8230 - 8239.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. Martin and P. Weber
Role of the DR2 repeat array in the regulation of the ICP34.5 gene promoter of herpes simplex virus type 1 during productive infection
J. Gen. Virol., March 1, 1998; 79(3): 517 - 523.
[Abstract]


Home page
BloodHome page
N. S. Prang, M. W. Hornef, M. Jager, H. J. Wagner, H. Wolf, and F. M. Schwarzmann
Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State
Blood, March 1, 1997; 89(5): 1665 - 1677.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1994 by the Society for General Microbiology.